<DOC>
	<DOCNO>NCT00185276</DOCNO>
	<brief_summary>The purpose study look safety ( side effect ) efficacy ( well work ) Magnevist ( study drug ) use MRI infrarenal aorta peripheral artery . The result compare result MRI take without Magnevist , result X-ray angiography .</brief_summary>
	<brief_title>MagnevistÂ® Injection Enhanced MRA Two Dose Levels Compared Non Contrast MRA Detection Structural Abnormalities Infrarenal Aorta Peripheral Arteries</brief_title>
	<detailed_description>This study previously post Berlex , Inc. Berlex , Inc. rename Bayer HealthCare Pharmaceuticals , Inc.Bayer HealthCare Pharmaceuticals , Inc.is sponsor trial .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Has know suspect peripheral vascular disease Is schedule Xray angiography Has contraindication magnetic resonance imaging Is schedule procedure Xray angiography Had previously stent place bilaterally region image</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Structural abnormality infrarenal aorta peripheral artery</keyword>
</DOC>